Sustained Delivery of Proteins for Novel Therapeutic Products

Abstract

R ecent developments in biotechnology have resulted in a number of powerful new protein therapies for many heretofore untreatable conditions, including hepatitis C, multiple sclerosis, hormonal disorders, and different cancers. In spite of this, the use of most protein drugs is limited by the